Bukwang Pharm: “Spinning Off Danish Subsidiary and Strengthening Momentum for RNA Therapeutics Development” Bukwang Pharm announced on the 18th that its Danish subsidiary Contera Pharma will spin off its RNA therapeutics… Park Pyeongtak 2025-11-18